(2R,3R)-2-(3',4'-dihydroxybenzyl)-3-(3'',4''-dimethoxybenzyl)butyrolactone(PP-6) suppresses fMLP-induced superoxide production by inhibiting fMLP-receptor binding in human neutrophils